![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 307/85 | (2006.01) |
(11) | Number of the document | 2744332 |
(13) | Kind of document | T |
(96) | European patent application number | 12826498.3 |
Date of filing the European patent application | 2012-08-10 | |
(97) | Date of publication of the European application | 2014-06-25 |
(45) | Date of publication and mention of the grant of the patent | 2016-10-26 |
(46) | Date of publication of the claims translation | 2017-01-10 |
(86) | Number | PCT/US2012/050268 |
Date | 2012-08-10 |
(87) | Number | WO 2013/028371 |
Date | 2013-02-28 |
(30) | Number | Date | Country code |
201161525440 P | 2011-08-19 | US | |
201261650681 P | 2012-05-23 | US |
(72) |
CHONG, Pek Yoke, US
MILLER, John F., US
PEAT, Andrew James, US
SHOTWELL, John Brad, US
|
(73) |
Glaxo Group Limited,
980 Great West Road Brentford, Middlesex TW8 9GS,
GB
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Benzofurano junginiai, skirti hepatito C viruso infekcijų gydymui |
BENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTIONS |
Payment date | Validity (years) | Amount | |
2019-08-05 | 8 | 185.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2020-08-10 |